Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists

被引：55

作者：

Ahn, HS ^{[1
]}

Arik, L ^{[1
]}

Boykow, G ^{[1
]}

Burnett, DA ^{[1
]}

Caplen, MA ^{[1
]}

Czarniecki, M ^{[1
]}

Domalski, MS ^{[1
]}

Foster, C ^{[1
]}

Manna, M ^{[1
]}

Stamford, AW ^{[1
]}

Wu, YS ^{[1
]}

机构：

[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 14期

关键词：

D O I：

10.1016/S0960-894X(99)00339-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of pyrroloquinazolines has been discovered that represent novel small molecule inhibitors of the intramolecular ligand of the thrombin receptor. Analogs were prepared to study the structure-activity relationships of substitution at the N1, N3, and N7 positions of the heterocycle. Compounds 4e and 4f have been identified with IC50's of 56 and 52 nM, respectively. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：2073 / 2078

页数：6

共 50 条

[11] Quantitative structure-activity relationships of benzoyliminothiadiazoline derivatives as angiotensin II receptor antagonists
Hirata, T
Goto, S
Tamura, K
Okuhira, M
Nagao, Y
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (04) : 385 - 388
[12] Highly selective endothelin antagonists for ET(A) receptor: Synthesis and structure-activity relationships
Liu, G
Henry, KJ
Szczepankiewicz, BG
Winn, M
Boyd, SA
Mantei, RA
Wasicak, J
vonGeldern, TW
WuWong, JR
Chiou, W
Dixon, D
Opgenorth, TJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 193 - MEDI
[13] Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships
Cheong, Siew Lee
Venkatesan, Gopalakrishnan
Paira, Priyankar
Jothibasu, Ramasamy
Mandel, Alexander Laurence
Federico, Stephanie
Spalluto, Giampiero
Pastorin, Giorgia
INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2011, 2011
[14] Quantitative structure-activity relationships of RGD mimetics as fibrinogen receptor antagonists.
Akamatsu, M
Miyashita, M
Nakagawa, Y
Hayashi, Y
Sato, Y
Ueno, T
Fujita, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U680 - U681
[15] An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships
Wang, Jiangming
Sun, Xiaojing
Li, Na
Sheng, Ruilong
Guo, Ruihua
CURRENT MEDICINAL CHEMISTRY, 2023, 30 (25) : 2864 - 2930
[16] Structure-activity relationships for synthetic peptides and peptidomimetics of thrombin
Clement, CC
Philipp, M
BIOCHEMISTRY, 2003, 42 (28) : 8631 - 8631
[17] Structure-activity relationships for synthetic peptide inhibitors of thrombin
Clement, CC
Gingold, J
Philipp, M
FASEB JOURNAL, 2003, 17 (05): : A1006 - A1006
[18] Agonist-antagonist structure-activity relationships of thrombin receptor tethered ligand peptide
Fujita, T
Nose, T
Nakajima, M
Inoue, Y
Nakamura, N
Inoue, T
Costa, T
Shimohigashi, Y
PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 202 - 204
[19] Novel γ-aminobutyric acid ρ1 receptor antagonists;: Synthesis, pharmacological activity and structure-activity relationships
Kumar, Rohan J.
Chebib, Mary
Hibbs, David E.
Kim, Hye-Lim
Johnston, Graham A. R.
Salam, Noeris K.
Hanrahan, Jane R.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3825 - 3840
[20] Quantitative structure-activity relationships of α1 adrenergic antagonists
Eric, S
Solmajer, T
Zupan, J
Novic, M
Oblak, M
Agbaba, D
JOURNAL OF MOLECULAR MODELING, 2004, 10 (02) : 139 - 150

← 1 2 3 4 5 →